Comet Therapeutics (formerly TM3) is a young biotech company co-founded by Enej Kuscer, Angelina Sekirnik and ACIES Bio in April 2017 in The Netherlands. The company focuses on the treatment of orphan neurological disorders through Coenzyme-A substitution therapy strategies.

Biopharmaceuticals